New inhaled therapy aims to stop lung decline after transplant
Disease control
Recruiting now
This Phase 3 trial tests an inhaled drug called ARINA-1 in 100 people who have had a double lung transplant and are showing early signs of lung function loss. The goal is to see if adding ARINA-1 to standard care can prevent further decline in lung function and improve quality of…
Phase: PHASE3 • Sponsor: Renovion, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC